Kumamoto, Japan

Yasuharu Nishimura

USPTO Granted Patents = 22 

 

 

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2010-2019

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):

Title: **Innovative Contributions of Yasuharu Nishimura in Cancer Immunotherapy**

Introduction

Yasuharu Nishimura, based in Kumamoto, Japan, is a prominent inventor and researcher known for his significant contributions to the field of immunology. With an impressive portfolio of 22 patents, his work focuses on developing epitope peptides for Th1 cells that enhance immune response, particularly in cancer treatment.

Latest Patents

Nishimura's latest patents include groundbreaking developments in CDCA1 and KIF20A epitope peptides. His patent on **CDCA1 epitope peptides for Th1 cells and vaccines containing the same** discloses isolated peptides that are recognized by MHC class II molecules, capable of inducing Th1 cells and CDCA1-specific cytotoxic T lymphocytes (CTLs). These peptides are designed to enhance immune response in a subject, making them suitable for cancer immunotherapy, especially as cancer vaccines. Furthermore, Nishimura has patented **KIF20A epitope peptides for Th1 cells and vaccines containing the same**. Similar to his CDCA1 work, these isolated peptides also can bind promiscuously to MHC class II molecules, inducing Th1 cells and KIF20A-specific CTLs, thereby contributing to the treatment and prevention of cancers or tumors.

Career Highlights

Throughout his career, Nishimura has worked with notable companies such as Oncotherapy Science, Incorporated and Medinet Co., Ltd. These experiences have allowed him to apply his innovative ideas and research in practical applications that address pressing issues in cancer treatment.

Collaborations

Nishimura has collaborated with esteemed colleagues in the field, including Takuya Tsunoda and Yusuke Nakamura. These partnerships have furthered his research and broadened the applicability of his innovations in creating effective immunotherapeutic solutions.

Conclusion

Yasuharu Nishimura's contributions through his patents significantly advance the field of immunology and cancer treatment. His innovative solutions, aimed at enhancing immune response, highlight the importance of research in developing effective therapies for complex diseases, reinforcing the critical role of inventors in transforming scientific inquiry into practical health advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…